Clarivate Plc Stock

Equities

CLVT

JE00BJJN4441

Professional Information Services

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
6.99 USD +0.58% Intraday chart for Clarivate Plc +1.90% -24.51%
Sales 2024 * 2.62B Sales 2025 * 2.69B Capitalization 4.67B
Net income 2024 * -49M Net income 2025 * 24M EV / Sales 2024 * 3.58 x
Net Debt 2024 * 4.69B Net Debt 2025 * 4.17B EV / Sales 2025 * 3.29 x
P/E ratio 2024 *
-79.8 x
P/E ratio 2025 *
195 x
Employees 12,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.02%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.58%
1 week+1.90%
Current month-5.92%
1 month-5.41%
3 months-24.02%
6 months+3.56%
Current year-24.51%
More quotes
1 week
6.59
Extreme 6.59
7.17
1 month
6.59
Extreme 6.59
7.77
Current year
6.55
Extreme 6.5506
9.61
1 year
6.07
Extreme 6.07
10.03
3 years
6.07
Extreme 6.07
34.79
5 years
6.07
Extreme 6.07
34.79
10 years
6.07
Extreme 6.07
34.79
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 22-07-10
Director of Finance/CFO 44 21-12-15
Chief Tech/Sci/R&D Officer - 22-01-31
Members of the board TitleAgeSince
Director/Board Member 81 19-04-30
Director/Board Member 63 16-09-30
Director/Board Member 74 20-05-06
More insiders
Date Price Change Volume
24-04-18 6.95 +0.58% 6,212,269
24-04-17 6.91 +1.77% 3,913,559
24-04-16 6.79 -1.02% 9,266,018
24-04-15 6.86 -2.97% 5,626,542
24-04-12 7.07 -3.81% 2,441,444

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
Clarivate Plc is an information services provider. The Company provides information, analytics, professional services and workflow solutions that enable users across government and academic institutions, life science and healthcare companies, corporations and law firms to power the entire lifecycle, from cultivating curiosity to protecting critical intellectual property assets. Its segments include Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The A&G segment provides curated, structured content, discovery solutions and related software applications that are embedded into the workflows of its customers, which include libraries, universities and research institutions. Its IP segment consists of patents, trademarks, and IP management products and solutions. The LS&H segment contains its products and solutions, which serve the content and analytical needs of pharmaceutical and biotechnology companies across the drug development lifecycle.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
6.95 USD
Average target price
8.13 USD
Spread / Average Target
+16.98%
Consensus